BEGIN:VCALENDAR
X-WR-TIMEZONE:Europe/LondonVERSION:2.0
PRODID:-//University of Liverpool//University Events//EN
BEGIN:VEVENT
UID:20260905T121027-112136-UniversityOfLiverpool
DTSTAMP:20260905T121027
DTSTART:20260512T130000
DTEND:20260512T140000
LOCATION:Physiology seminar room, Nuffield Wing, 
SUMMARY:Professor Maria Hawkins, UCL - 'Exploring primary resistance of colorectal cancer to chemoradiation'
DESCRIPTION:LIVERPOOL CANCER SEMINAR SERIES: SPONSORED BY NORTH WEST CANCER RESEARCH Professor Maria Hawkins is a clinician scientist in precision radiotherapy committed to improving outcomes through research investigating effects in normal tissue and novel agents-- novel radiation combinations. From 2012 to 2019 she was an MRC Group leader, in Oxford Institute for Radiation Oncology, University of Oxford. She was appointed Professor of Radiotherapy at University College London in 2019 and is currently the clinical director of CRUK City of London Radiation Centre of Excellence, and director of radiotherapy translational research at UCL/UCLH.Her research investigates the use of AI using multimodal data (imaging, pathology, genomics, radiation dose and clinical features) to develop better patient selection with a focus on gastro-intestinal malignancies, and developing 3D models (precision cut tumour/tissue slices) to study early radiation effect.She has developed and currently testing in clinical trials, novel radiotherapy including protons in cancers of unmet need (oesophagus pancreas, hepatobilliary) and findings of radiobiology research have been investigated in national studies. Professor Hawkins is the chief investigator of four CRUK funded trials including radiation novel agent combinations in phase I (in oesophageal cancer), and the preoperative proton vs photon radiation surgery and immune treatment study, and for proton therapy as bridge to transplant in cholangiocarcinoma, proton therapy as bridge to CAR-T cell therapy in relapsed glioblastoma trials.All welcome.
END:VEVENT
END:VCALENDAR